Richard L Eckert

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Topics

Natural Killer Cells

Top Venues

Molecular carcinogenesis

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Gautam Adhikary, Erica L Heipertz, Maja Preradovic, Xi Chen, Wen Xu, John J Newland, Navjot Kaur, Mohan C Vemuri, Richard L Eckert
Natural killer cells suppress human cutaneous squamous cell carcinoma cancer cell survival and tumor growth. Molecular carcinogenesis (2023)
Xi Chen, Gautam Adhikary, John J Newland, Wen Xu, Jeffrey W Keillor, David J Weber, Richard L Eckert
Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6/ERK1/2 signaling and maintain an aggressive cancer phenotype. Molecular cancer research : MCR (2023)
Xi Chen, Gautam Adhikary, John J Newland, Wen Xu, Emily Ma, Warren Naselsky, Richard L Eckert
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype. Molecular carcinogenesis (2022)
Warren Naselsky, Gautam Adhikary, Suruchi Shrestha, Xi Chen, Geraldine Ezeka, Wen Xu, Joseph S Friedberg, Richard L Eckert
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype. Molecular carcinogenesis 61 (6) (2022)
Xi Chen, Gautam Adhikary, Emily Ma, John J Newland, Warren Naselsky, Wen Xu, Richard L Eckert
Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype. Molecular carcinogenesis (2022)
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J Newland, Xi Chen, Wen Xu, Ashkan Emadi, Joseph S Friedberg, Richard L Eckert
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation. Molecular carcinogenesis 62 (4) (2022)
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J Newland, Xi Chen, Wen Xu, Ashkan Emadi, Joseph S Friedberg, Richard L Eckert
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation. Molecular carcinogenesis (2022)
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J Newland, Xi Chen, Wen Xu, Ashkan Emadi, Joseph S Friedberg, Richard L Eckert
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation. Molecular carcinogenesis 62 (4) (2022)
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J Newland, Xi Chen, Wen Xu, Ashkan Emadi, Joseph S Friedberg, Richard L Eckert
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation. Molecular carcinogenesis 62 (4) (2022)
Ellen A Rorke, Gautam Adhikary, Henryk Szmacinski, Joseph R Lakowicz, David J Weber, Raquel Godoy-Ruiz, Purushottamachar Puranik, Jeffrey W Keillor, Eric W J Gates, Richard L Eckert
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity. Molecular carcinogenesis 61 (1) (2021)
McKayla Mickle, Gautam Adhikary, Suruchi Shrestha, Wen Xu, Richard L Eckert
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype. Molecular carcinogenesis 60 (7) (2021)
Xi Chen, Gautam Adhikary, Suruchi Shrestha, Wen Xu, Jeffrey W Keillor, Warren Naselsky, Richard L Eckert
Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype. Molecular cancer research : MCR 19 (12) (2021)
Geraldine Ezeka, Gautam Adhikary, Sivaveera Kandasamy, Joseph S Friedberg, Richard L Eckert
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype. Molecular carcinogenesis 60 (7) (2021)
Suruchi Shrestha, Gautam Adhikary, Warren Naselsky, Wen Xu, Joseph S Friedberg, Richard L Eckert
ACTL6A suppresses p21Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype. Oncogenesis 10 (10) (2021)
Suruchi Shrestha, Gautam Adhikary, Wen Xu, Sivaveera Kandasamy, Richard L Eckert
ACTL6A suppresses p21Cip1 expression to enhance the epidermal squamous cell carcinoma phenotype. Oncogene 39 (36) (2020)
Richard L Eckert
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target. Molecular carcinogenesis 58 (6) (2019)
Daniel Grun, Gautam Adhikary, Richard L Eckert
NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival. Molecular carcinogenesis 58 (4) (2018)
Candace Kerr, Gautam Adhikary, Daniel Grun, Nicholas George, Richard L Eckert
Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Molecular carcinogenesis 57 (1) (2017)